These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 26875037)

  • 1. [Conflict of interest in continuing medical education - Studies on certified CME courses].
    Lenzen LM; Weidringer JW; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical-industrial complex, professional medical associations, and continuing medical education.
    Schofferman J
    Pain Med; 2011 Dec; 12(12):1713-9. PubMed ID: 22145759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uncertain future of continuing medical education: commercialism and shifts in funding.
    Van Harrison R
    J Contin Educ Health Prof; 2003; 23(4):198-209. PubMed ID: 14730790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sponsorship and conflicts of interests in CME: the Italian experience.
    Villani G
    Med Law; 2009 Mar; 28(2):197-209. PubMed ID: 19705637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Continuing medical education in Germany--the northrhenian experience].
    Griebenow R; Lösche P; Lehmacher W; Schmülling A; Chon S; Christ H; Stützer H; Stosch Ch
    Dtsch Med Wochenschr; 2003 Apr; 128(14):734-8. PubMed ID: 12673528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal.
    Rodwin MA
    J Law Med Ethics; 2010; 38(4):807-15. PubMed ID: 21105944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in drug prescribing patterns related to commercial company funding of continuing medical education.
    Bowman MA; Pearle DL
    J Contin Educ Health Prof; 1988; 8(1):13-20. PubMed ID: 10294441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of sponsored and unsponsored continuing medical education].
    Chon SH; Lösche P; Christ H; Lehmacher W; Griebenow R
    Med Klin (Munich); 2008 May; 103(5):341-5. PubMed ID: 18484220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflict of interest-draining the swamp means confronting alligators.
    Wyse DG
    J Interv Card Electrophysiol; 2005 Jun; 13(1):5-7. PubMed ID: 15976972
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical relationships between drug companies and the medical profession.
    Rosner F
    Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765
    [No Abstract]   [Full Text] [Related]  

  • 12. Commercial support of continuing medical education in the United States: the politics of doubt, the value of studies.
    Mazmanian PE
    J Contin Educ Health Prof; 2009; 29(2):81-3. PubMed ID: 19530200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of industry support on participants' perceptions of bias in continuing medical education.
    Kawczak S; Carey W; Lopez R; Jackman D
    Acad Med; 2010 Jan; 85(1):80-4. PubMed ID: 20042829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Continuing Medical Education (CME) events cover the content physicians want to know? A content analysis of CME offerings.
    Bjerre LM; Paterson NR; McGowan J; Hogg W; Campbell C; Viner G; Archibald D
    J Contin Educ Health Prof; 2015; 35(1):27-37. PubMed ID: 25799970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Declaration of financial and non-financial interests in CME courses of Springer Medizin : Implementation of the regulation on the "Code on Continuing Medical Education" of the Medical Chamber North Rhine].
    Herrmann P; Griebenow R
    Internist (Berl); 2019 Jul; 60(7):709-710. PubMed ID: 31243511
    [No Abstract]   [Full Text] [Related]  

  • 16. A risk stratification tool to assess commercial influences on continuing medical education.
    Barnes BE; Cole JG; King CT; Zukowski R; Allgier-Baker T; Rubio DM; Thorndyke LE
    J Contin Educ Health Prof; 2007; 27(4):234-40. PubMed ID: 18085603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality and structure of continuing medical education in internal medicine using the example of the Chamber of Physicians of the northern Rhine area].
    von Reis EO; Bott U; Sawicki PT
    Z Arztl Fortbild Qualitatssich; 1999 Oct; 93(8):569-79. PubMed ID: 10596038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A model project on certification of continuous education by the Bavarian Chamber of Physicians].
    Koch HH; Amarotico E; Weidringer JW; Inglis R
    Z Arztl Fortbild Qualitatssich; 1999 Oct; 93(8):551-4. PubMed ID: 10596034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-line delivery of continuing medical education over the World-Wide Web: an on-line needs assessment.
    Richardson ML; Norris TE
    AJR Am J Roentgenol; 1997 May; 168(5):1161-4. PubMed ID: 9129405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.